Medicare Enrolled
Dr. Thadeus Dapash, D.O
Gastroenterology · Charlotte, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dapash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dapash?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dapash
Dr. Thadeus Dapash is a gastroenterology specialist in Charlotte, NC, with 11 years of NPI registration. Based on federal Medicare data, Dr. Dapash performed 666 Medicare services across 620 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dapash received a total of $13,985 from 51 pharmaceutical and/or device companies across 650 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dapash is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 40% volume in NC
$13,985 industry payments
Medicare Practice Summary
Medicare Utilization ↗666
Medicare services
Top 40% in NC for gastroenterology
620
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
116 | $69 | $583 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
91 | $67 | $176 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
72 | $198 | $1,045 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $100 | $326 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $87 | $260 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
43 | $50 | $172 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $71 | $263 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
39 | $125 | $882 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $91 | $400 |
| Dilation of esophagus | 36 | $29 | $306 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
31 | $177 | $735 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
29 | $123 | $735 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
16 | $68 | $495 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
13 | $170 | $735 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,985
Total received (2018-2024)
Avg $1,998/year across 7 years
Top 13% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
650
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,888 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$97 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,082
2023
$2,162
2022
$1,671
2021
$2,986
2020
$1,741
2019
$794
2018
$549
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,067
Janssen Biotech, Inc.
$558
Phathom Pharmaceuticals, Inc.
$264
GENZYME CORPORATION
$223
Takeda Pharmaceuticals U.S.A., Inc.
$218
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$189
VIVUS LLC
$189
Janssen Scientific Affairs, LLC
$149
3-D Matrix, Inc.
$144
AIMMUNE THERAPEUTICS, INC.
$124
Medtronic, Inc.
$110
Regeneron Healthcare Solutions, Inc.
$109
Celgene Corporation
$86
Ipsen Biopharmaceuticals, Inc
$84
Lilly USA, LLC
$72
Gilead Sciences, Inc.
$63
Merck Sharp & Dohme LLC
$59
Organon Llc
$56
Madrigal Pharmaceuticals
$45
QOL Medical, LLC
$40
Celltrion USA Inc.
$38
IRONWOOD PHARMACEUTICALS, INC
$37
Ardelyx, Inc.
$30
Alcresta Therapeutics, Inc.
$28
Ultragenyx Pharmaceutical Inc.
$19
Fresenius Kabi USA, LLC
$18
Sandoz Inc.
$17
PFIZER INC.
$17
Intercept Pharmaceuticals, Inc.
$16
Eisai Inc.
$13
Top 3 companies account for 46.3% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$2,101
ABBVIE INC.
$2,086
Janssen Biotech, Inc.
$1,178
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,073
Takeda Pharmaceuticals U.S.A., Inc.
$831
GENZYME CORPORATION
$437
PFIZER INC.
$398
Daiichi Sankyo Inc.
$348
AbbVie, Inc.
$346
Axonics, Inc.
$294
Janssen Scientific Affairs, LLC
$274
Phathom Pharmaceuticals, Inc.
$264
Amarin Pharma Inc.
$241
Ardelyx, Inc.
$234
VIVUS LLC
$216
Amgen Inc.
$213
Boehringer Ingelheim Pharmaceuticals, Inc.
$198
RedHill Biopharma Inc.
$197
Novo Nordisk Inc
$193
Ferring Pharmaceuticals Inc.
$189
Celgene Corporation
$174
Regeneron Healthcare Solutions, Inc.
$171
Gilead Sciences, Inc.
$165
3-D Matrix, Inc.
$144
Intercept Pharmaceuticals, Inc.
$142
QOL Medical, LLC
$131
Braintree Laboratories, Inc.
$127
E.R. Squibb & Sons, L.L.C.
$125
AIMMUNE THERAPEUTICS, INC.
$124
Allergan Inc.
$118
Merck Sharp & Dohme LLC
$116
Ironwood Pharmaceuticals, Inc
$112
AstraZeneca Pharmaceuticals LP
$112
Medtronic, Inc.
$110
Lilly USA, LLC
$101
Nestle HealthCare Nutrition Inc.
$100
NESTLE HEALTHCARE NUTRITION INC.
$87
IRONWOOD PHARMACEUTICALS, INC
$86
Ipsen Biopharmaceuticals, Inc
$84
Organon Llc
$56
Madrigal Pharmaceuticals
$45
Exact Sciences Corporation
$41
Celltrion USA Inc.
$38
Sandoz Inc.
$37
Alcresta Therapeutics, Inc.
$28
EISAI INC.
$20
Ultragenyx Pharmaceutical Inc.
$19
Fresenius Kabi USA, LLC
$18
INTERCEPT PHARMACEUTICALS, INC.
$18
Novartis Pharmaceuticals Corporation
$14
Eisai Inc.
$13
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Axonics · BYDUREON · Bylvay · CIMZIA · CREON · CYRAMZA · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · Dojolvi · ENTRESTO · ENTYVIO · Enbrel · Epclusa · FORTEO · GATTEX · GI GENIUS · HADLIMA · HUMIRA · HYRIMOZ · Humira · IBSRELA · IDACIO · INJECTAFER · INTERSTIM · IQIRVO · JARDIANCE · LINZESS · Lenvima · Linzess · MAVYRET · MOTOFEN · MOVANTIK · Mavyret · Motegrity · Movantik · Norditropin · OCALIVA · OMVOH · ONTRUZANT · PANCREAZE · Qsymia · REBYOTA · RELISTOR · RELIZORB · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUTAB · Saxenda · Sucraid · TREMFYA · TRULANCE · Talicia · VEGZELMA · VIBERZI · VOQUEZNA · Vascepa · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
85
Per 100K population
7.5
County median income
$83,765
Nearest hospital
ATRIUM HEALTH PINEVILLE
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dapash is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of NC peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dapash experienced with upper gi endoscopy with biopsy?
Based on Medicare claims data, Dr. Dapash performed 116 upper gi endoscopy with biopsy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dapash receive payments from pharmaceutical companies?
Yes. Dr. Dapash received a total of $13,985 from 51 companies across 650 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dapash's costs compare to other gastroenterologists in Charlotte?
Dr. Dapash's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dapash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Charlotte
Browse gastroenterologists in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NC
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NC
Which NC gastroenterologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology